Literature DB >> 574057

Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.

C E Merrin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 574057

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  15 in total

1.  Cytomorphological lesions induced by chemotherapeutic agents in transitional cell carcinoma in vitro.

Authors:  D J Weaver; B A Barrett; G Ross; E H Adelstein
Journal:  In Vitro Cell Dev Biol       Date:  1986-11

Review 2.  Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review.

Authors:  V Pinzani; F Bressolle; I J Haug; M Galtier; J P Blayac; P Balmès
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Intolerance to cisplatin--a case report.

Authors:  G E Umbach; H von Matthiessen; G Wirth; G Goerz
Journal:  Arch Gynecol       Date:  1985

4.  Adjuvant chemotherapy for invasive bladder cancer.

Authors:  Y Uekado; T Shinka; A Hirano; T Ohkawa
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Phase I study of oxaliplatin in patients with advanced cancer.

Authors:  J M Extra; M Espie; F Calvo; C Ferme; L Mignot; M Marty
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Renal function, serum calcium and magnesium during treatment of advanced bladder carcinoma with cis-dichlorodiamineplatinum: impact of tumour site, patient age and magnesium suppletion.

Authors:  J H Blom; K H Kurth; T A Splinter
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

7.  Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.

Authors:  M M Regan; E K O'Donnell; W K Kelly; S Halabi; W Berry; S Urakami; N Kikuno; W K Oh
Journal:  Ann Oncol       Date:  2009-07-24       Impact factor: 32.976

8.  Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

Authors:  A H Calvert; S J Harland; D R Newell; Z H Siddik; A C Jones; T J McElwain; S Raju; E Wiltshaw; I E Smith; J M Baker; M J Peckham; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.

Authors:  M Satoh; A Naganuma; N Imura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 10.  Chemotherapy of advanced transitional-cell carcinoma of the bladder.

Authors:  R S Miller; F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.